Geron | GERN - Выручка от реализации





Продажи Изменить Дата
Amgen USD 8.62B 1.28B 2026-03
Bio Techne USD 311.4M 15.5M 2026-03
Cytokinetics USD 19.35M 1.59M 2026-03
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Exelixis USD 610.8M 12.14M 2026-03
Genmab DKK 1.06B 36M 2025-12
Geron USD 51.84M 3.82M 2026-03
Gilead Sciences USD 7B 930M 2026-03
Incyte USD 1.27B 240M 2026-03
MacroGenics USD 20.8M 20.43M 2026-03
Novartis USD 13.11B 226M 2026-03
Novavax USD 147.14M 76.69M 2025-12